Clinical Trial Update: 3-AP in Treating Patients With Advanced Prostate Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating 3-AP (Triapine) for advanced prostate cancer conducted by Vion Pharmaceuticals has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• 3-AP

Snippet

Sponsor: Vion Pharmaceuticals | Conditions: Prostate Cancer | Phase 2 | Status: COMPLETED